Patent ID: 7645773
Filing Date: 2010-01-12
Classification: A61P,C07D

Abstract:
1. A compound of the formula (I): wherein: R one of R or R or a pharmaceutically acceptable salt thereof, with the proviso that the following compounds are excluded: [2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazol-4-yl]-pyrrolidin-1-yl-methanone; [2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazol-4-yl]-morpholin-4-yl-methanone; (4-Phenyl-3,6-dihydro-2H-pyridin-1-yl)-(2-phenyl-thiazol-4-yl)-methanone; (2-Benzo[1,2,5]oxadiazol-5-yl-thiazol-4-yl)-morpholin-4-yl-methanone; Morpholin-4-yl-(2-pyridin-3-yl-thiazol-4-yl)-methanone [2-(4-Methyl-pyridin-3-yl)-thiazol-4-yl]-pipendin-1-yl-methanone; [2-(4-Methyl-pyridin-3-yl)-thiazol-4-yl]-morpholin-4-yl-methanone; [2-(5-Methyl-isoxazol-3-yl)-thiazol-4-yl]-pipendin-1-yl-methanone; and [2-(3-Methyl-5-trifluoromethyl-pyrazol-1-yl)-thiazol-4-yl]-morpholin-4-yl-methanone.